Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm

ObjectiveThis study aims to determine the outcomes of transcaval embolization (TCE) for type II endoleak after infrarenal endovascular aortic repair (EVAR) and fenestrated/branched EVAR (F/BEVAR).MethodsA retrospective single-center cohort all consecutive TCE procedures between August 2015 2019 was performed investigate technical success, in-hospital morbidity, 30-day mortality as well clinical success during follow-up. The indication an aneurysm sac growth 5 mm or more owing a F/BEVAR juxtarenal IV thoracoabdominal aneurysm.ResultsA total 25 in 24 patients (95.8% male) were included. Technical 96.0% (24/25); selective nonselective 48% patients. morbidity 0%. median follow-up 23.1 months (interquartile range, 10.9-40.1 months). Freedom from endoleak-related reintervention 84.6% at 12 months. Comparing TCE, necessary 16.7% 20% TCE. Regarding vs F/BEVAR, 12.5% 33.3% follow-up.ConclusionsTCE is acceptable treatment alternative with enlargement can be used abdominal aneurysms aneurysms.